450 related articles for article (PubMed ID: 28495497)
1. Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature.
Snast I; Atzmony L; Braun M; Hodak E; Pavlovsky L
J Am Acad Dermatol; 2017 Jul; 77(1):88-97.e5. PubMed ID: 28495497
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection.
Megna M; Patruno C; Bongiorno MR; Gambardella A; Guarneri C; Romita P; Raimondo A; Loconsole F; Fabbrocini G
Clin Drug Investig; 2022 Jun; 42(6):525-531. PubMed ID: 35633470
[TBL] [Abstract][Full Text] [Related]
3. Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study.
Chiu HY; Chiu YM; Chang Liao NF; Chi CC; Tsai TF; Hsieh CY; Hsieh TY; Lai KL; Chiu TM; Wu NL; Hui RC; Lee CN; Wang TS; Chen PH; Yang CC; Huang YH
J Am Acad Dermatol; 2021 Aug; 85(2):337-344. PubMed ID: 31821860
[TBL] [Abstract][Full Text] [Related]
4. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations.
Piaserico S; Messina F; Russo FP
Am J Clin Dermatol; 2019 Dec; 20(6):829-845. PubMed ID: 31222626
[TBL] [Abstract][Full Text] [Related]
5. Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study.
Chiu HY; Hui RC; Huang YH; Huang RY; Chen KL; Tsai YC; Lai PJ; Wang TS; Tsai TF
Acta Derm Venereol; 2018 Oct; 98(9):829-834. PubMed ID: 29972221
[TBL] [Abstract][Full Text] [Related]
6. Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database.
Sanz-Bueno J; Vanaclocha F; García-Doval I; Torrado R; Carretero G; Daudén E; Patricia Ruiz-Genao D; Alsina-Gibert MM; Pérez-Zafrilla B; Pérez-Rial G; Rivera R;
Actas Dermosifiliogr; 2015; 106(6):477-82. PubMed ID: 25776200
[TBL] [Abstract][Full Text] [Related]
7. Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab.
Ting SW; Chen YC; Huang YH
Clin Drug Investig; 2018 Sep; 38(9):873-880. PubMed ID: 29968197
[TBL] [Abstract][Full Text] [Related]
8. Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV.
Ogawa E; Furusyo N; Murata M; Toyoda K; Hayashi T; Ura K
Liver Int; 2018 Jan; 38(1):76-83. PubMed ID: 28618152
[TBL] [Abstract][Full Text] [Related]
9. The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.
Chiu HY; Chen CH; Wu MS; Cheng YP; Tsai TF
Br J Dermatol; 2013 Dec; 169(6):1295-303. PubMed ID: 23746170
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients.
Markovic S; Drozina G; Vovk M; Fidler-Jenko M
Hepatogastroenterology; 1999; 46(29):2925-30. PubMed ID: 10576374
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice.
Loggi E; Gitto S; Galli S; Minichiello M; Conti F; Grandini E; Scuteri A; Vitale G; Di Donato R; Cursaro C; Furlini G; Andreone P
J Clin Virol; 2017 Aug; 93():66-70. PubMed ID: 28654775
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis.
Morisco F; Guarino M; La Bella S; Di Costanzo L; Caporaso N; Ayala F; Balato N
BMC Gastroenterol; 2014 Dec; 14():214. PubMed ID: 25523080
[TBL] [Abstract][Full Text] [Related]
13. Reactivation rates of hepatitis B or C or HIV in patients with psoriasis using biological therapies: a systematic review and meta-analysis.
Li L; Jiang X; Fu L; Zhang L; Feng Y
Clin Exp Med; 2023 Jul; 23(3):701-715. PubMed ID: 35499793
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV).
Pisaturo M; Macera M; Alessio L; Calò F; Coppola N
Viruses; 2019 Sep; 11(9):. PubMed ID: 31540223
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals.
Belperio PS; Shahoumian TA; Mole LA; Backus LI
Hepatology; 2017 Jul; 66(1):27-36. PubMed ID: 28240789
[TBL] [Abstract][Full Text] [Related]
16. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study.
Tien YC; Yen HH; Li CF; Liu MP; Hsue YT; Hung MH; Chiu YM
Arthritis Res Ther; 2018 Nov; 20(1):246. PubMed ID: 30382902
[TBL] [Abstract][Full Text] [Related]
17. Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data.
El Kassas M; Shimakawa Y; Ali-Eldin Z; Funk AL; Wifi MN; Zaky S; El-Raey F; Esmat G; Fontanet A
Liver Int; 2018 Dec; 38(12):2159-2169. PubMed ID: 29738637
[TBL] [Abstract][Full Text] [Related]
18. Differences in the patterns and outcomes of enhanced viral replication between hepatitis C virus and hepatitis B virus in patients with hepatocellular carcinoma during transarterial chemolipiodolization.
Sung PS; Bae SH; Jang JW; Song DS; Kim HY; Yoo SH; Park CH; Kwon JH; Song MJ; You CR; Choi JY; Yoon SK
Korean J Hepatol; 2011 Dec; 17(4):299-306. PubMed ID: 22310794
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES.
Butt AA; Yan P; Shaikh OS; Abou-Samra AB
Aliment Pharmacol Ther; 2018 Feb; 47(3):412-420. PubMed ID: 29181838
[TBL] [Abstract][Full Text] [Related]
20. High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.
Cho Y; Yu SJ; Cho EJ; Lee JH; Kim TM; Heo DS; Kim YJ; Yoon JH
J Med Virol; 2016 Jun; 88(6):1010-7. PubMed ID: 26531242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
